The Hindu Business Line : Monday, December 27, 2004

IPR
Drugs, patents and options
While economists recognise the need for continuing R&D, they feel that options other than the current patent system must be explored which can encourage research and, at the same time, keep new drugs affordable. Under the prevailing fiscal proble n all countries, government funds for research would be inadequate and the government research organisations may like to play safe, affecting risky innovation. More

CHANNELS AND FRANCHISES
TVS Motor dealership
HYDERABAD: TVS Motor Company has announced its new dealership to Susheel TVS at Kukkatpally in Hyderabad. Genuine spare parts, trained staff, workshop of international standards and finance scheme at low interest would be made available ... More

RETAILING
IBM showroom in Mangalore
MANGALORE: Binary Systems Pvt Ltd opened `Think World,' an exclusive showroom of IBM ThinkPad and ThinkCentre PCs, in Mangalore on Friday. Mr Harish Kumar Shetty, Chairman of Binary Systems Pvt Ltd, told reporters here that this is the ... More

Brand Quest

Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line

Pick a Winner Stock Market Contest

Cipla, Ranbaxy working on anti-AIDS drugs for kids

Petronet gets nod to in-charter tanker

`We can meet bulk demands from textile retailers'

Changes in Bill to give patents for software

`Discard a pet hypothesis every day before breakfast'

Rise in cashew exports to US

Economic blockade hits goods transport in Nepal